The secretion of interleukin-6 (IL-6) from MSCs increases the secretion of endothelin-1 (ET-1) in colorectal cancer cells, which activates Akt and ERK in endothelial cells, thus enhancing their capacities for vessel formation [35]. The gene discussed is IL6; the disease is colorectal cancer.